Jefferies Financial Group Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX)
Equities researchers at Jefferies Financial Group assumed coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a report released on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 175.12% from the stock’s […]
Equities researchers at Jefferies Financial Group assumed coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a report released on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 175.12% from the stock’s […]
